Choosing Your Listing Venue: A Comparative Framework for Hong Kong, New York, and London

The decision of where to list has never been purely a financial calculation, but for companies considering their options in the first half of 2025, the calculus has shifted materially. Hong Kong saw HKD 87.5 billion raised via IPOs in 2024, a 68% increase year-on-year, according to data compiled by the HKEX, driven largely by a wave of A-share listed companies and consumer sector issuers. Across the Pacific, the New York Stock Exchange raised USD 23.4 billion in the same period, while London’s main market recorded just GBP 1.3 billion in new listings, a 15-year low. These figures are not static snapshots; they reflect a fundamental realignment driven by distinct regulatory philosophies, geopolitical currents, and market liquidity profiles. For a CFO or sponsor evaluating a listing venue for 2025–2026, the choice is no longer a binary between Hong Kong and New York, but a tripartite assessment involving London’s post-Brexit reforms, the SEC’s tightening stance on Chinese-based issuers, and the HKEX’s targeted enhancements to its listing regime. This article provides a comparative framework grounded in specific regulatory references, market mechanics, and jurisdictional trade-offs.

Hong Kong: The Refined Gateway

Hong Kong’s position as the primary offshore listing venue for Chinese enterprises remains structurally entrenched, but its appeal now extends to Southeast Asian and Middle Eastern issuers seeking a capital markets platform with deep linkage to the PRC. The HKEX’s 2024–2025 strategic initiatives have focused on reducing time-to-market and expanding sector eligibility, addressing historic friction points for high-growth and pre-revenue companies.

Chapter 18C and the Specialist Technology Play

The HKEX introduced Chapter 18C of the Main Board Listing Rules in March 2023, creating a dedicated pathway for specialist technology companies. As of Q1 2025, 12 issuers have listed under this chapter, with a combined market capitalisation of approximately HKD 180 billion at listing. The rule permits a reduced minimum market capitalisation of HKD 6 billion (down from HKD 8 billion under the general Main Board requirement) for companies in sectors including next-generation information technology, advanced hardware, and new energy. Critically, Chapter 18C waives the standard requirement for a positive net profit record, substituting it with an expected market capitalisation threshold of HKD 15 billion for pre-revenue companies. This is a direct structural response to the NYSE’s and NASDAQ’s historical dominance in hosting pre-profit tech firms. The SFC and HKEX jointly issued a consultation conclusion in December 2024 (SFC/HKEX Joint Consultation Paper on Listing Regime for Specialist Technology Companies, December 2024) that further clarified the “expected market capitalisation” valuation methodology, requiring sponsors to provide a third-party valuation report from a qualified independent valuer for any pre-revenue applicant.

Chapter 18B for SPACs: The Second Wave

Hong Kong’s SPAC regime, effective 1 January 2022, has not generated the volume seen in the US, but the quality of transactions has been higher. As of February 2025, five SPACs have completed de-SPAC transactions on the Main Board, with an average deal size of HKD 3.8 billion. The HKEX’s Listing Decision LD143-2024 (HKEX, September 2024) clarified that a SPAC’s business combination target must meet the same suitability and financial eligibility tests as a traditional IPO applicant, including the three-year trading record requirement under Rule 8.05. This effectively prevents SPACs from being used as a shortcut for companies that cannot satisfy the standard Main Board financial tests. For issuers, the key trade-off is speed versus certainty: a SPAC transaction can close in 12–18 months from target identification, compared to 6–9 months for a traditional IPO, but the regulatory scrutiny on the target’s business model and valuation is no less intense.

The GEM Transfer Path

The Growth Enterprise Market (GEM) remains a viable staging ground for smaller issuers, but the transfer mechanism to the Main Board has been streamlined. Under the amended GEM Listing Rules effective 1 January 2024, a GEM issuer may apply for a transfer if it has a market capitalisation of at least HKD 500 million at the time of application and has maintained a 12-month trading record on GEM. The HKEX’s 2024 annual review of GEM (HKEX, January 2025) reported that 14 companies successfully transferred to the Main Board in 2024, with an average time from GEM listing to transfer of 28 months. This path is most suitable for companies that need an initial public market presence but are not yet ready for the full Main Board compliance burden, such as the quarterly financial reporting requirement under Rule 13.28.

New York: The Deep Pool with Rising Tides

The US capital markets remain the deepest and most liquid in the world, but the regulatory and geopolitical risks for non-US issuers, particularly those with significant PRC operations, have escalated materially since the Holding Foreign Companies Accountable Act (HFCAA) became operative in 2021.

The PCAOB Access Question

The Public Company Accounting Oversight Board (PCAOB) secured full access to inspect audit working papers of Chinese and Hong Kong-based accounting firms in December 2022, and the HFCAA’s delisting threat has receded for the near term. However, the SEC’s Division of Corporation Finance continues to apply enhanced scrutiny to issuers structured through Variable Interest Entities (VIEs). In a series of comment letters issued in Q3 2024, the SEC required VIE-structured registrants to provide a detailed narrative of the PRC government’s ability to intervene in the VIE’s operations and the specific contractual arrangements that give the issuer control. The SEC’s Staff Legal Bulletin No. 14M (SEC, June 2024) explicitly states that a VIE structure alone does not satisfy the control requirement under Rule 12b-2 of the Securities Exchange Act of 1934, and that the issuer must demonstrate de facto control through equity ownership or board representation. For a PRC-based company, this means that a pure VIE structure without a direct equity interest in the operating entity is now a significant disclosure risk, potentially requiring a restatement of the prospectus.

Listing Standards and Market Capitalisation

The NYSE’s initial listing standards require a minimum market capitalisation of USD 100 million for domestic companies and USD 200 million for foreign private issuers (FPIs), with a minimum share price of USD 4.00. The NASDAQ’s standards are slightly more granular: under its Global Select Market, an FPI must meet a minimum market capitalisation of USD 85 million and a minimum bid price of USD 4.00. For a Hong Kong-based or PRC-based issuer, the practical threshold is higher: underwriters typically require a pre-IPO valuation of at least USD 500 million to justify the costs of a US listing, which include SEC registration fees, legal counsel fees (typically USD 3–5 million for a first-time FPI), and ongoing compliance costs under Section 404 of the Sarbanes-Oxley Act (SOX). The SOX 404(b) auditor attestation requirement applies to FPIs with a public float of USD 75 million or more, adding an estimated USD 500,000–1.5 million annually in audit and consulting costs.

The SPAC Arbitrage

The US SPAC market has contracted sharply from its 2021 peak of USD 162 billion in gross proceeds. In 2024, US SPAC IPOs raised only USD 8.7 billion, and the average trust redemption rate for de-SPAC transactions exceeded 65% (SPAC Research, Q4 2024 data). For a non-US issuer, the US SPAC path now carries significant execution risk: the high redemption rate means the sponsor must secure a committed PIPE (Private Investment in Public Equity) of at least 100–150% of the anticipated redemptions to ensure the transaction closes. The SEC’s proposed rules on SPACs (SEC Release 33-11048, March 2022, still pending finalisation as of Q1 2025) would require the target company to be deemed a co-registrant for the business combination proxy statement, exposing the target’s directors to Section 11 liability under the Securities Act of 1933. This has made US SPACs a less attractive option for Hong Kong-based issuers compared to the HKEX’s SPAC regime, where the target’s liability is more circumscribed.

London: The Post-Brexit Recalibration

The London Stock Exchange (LSE) has undergone its most significant listing regime reform in three decades, with the introduction of the Equity Listing Rules (ELR) effective 29 July 2024. The reforms aim to reverse the exodus of issuers to New York and Hong Kong, but the data so far suggests a mixed outcome.

The Single Listing Category and Free Float Reduction

The most consequential change is the abolition of the “premium” and “standard” listing segments, replaced by a single “Equity Shares (Commercial Companies)” category. This eliminates the two-tier system that historically gave premium-listed companies access to the FTSE UK Index Series but subjected them to the UK’s super-equivalent corporate governance requirements. Under the new ELR, the minimum free float requirement has been reduced from 25% to 10% (LSEG Rule 2.2.1, as amended July 2024). For a Hong Kong-based issuer, this is a material structural advantage: a 10% free float allows the founding shareholders to retain a larger controlling stake while still achieving a public listing. By comparison, the HKEX requires a minimum 25% public float under Rule 8.08(1)(a) for Main Board issuers, though the HKEX may accept a lower percentage (minimum 15%) for a company with an expected market capitalisation of over HKD 10 billion at listing.

The Sponsor Regime and Due Diligence Standard

The UK’s sponsor regime, administered by the Financial Conduct Authority (FCA), requires a sponsor to be appointed for any applicant seeking admission to the LSE’s main market. The FCA’s Handbook (LR 8.3.4R) requires the sponsor to confirm that it has made “reasonable enquiries” to verify that the applicant has satisfied the conditions for listing. This standard is comparable to the HKEX’s sponsor regime under the Code of Conduct for Persons Licensed by or Registered with the SFC (SFC Code, paragraph 17.6), which requires a sponsor to exercise “reasonable skill, care, and diligence” in conducting due diligence. However, the UK standard places a heavier burden on the sponsor to identify and disclose any material information that might affect the applicant’s suitability, even if that information is not directly requested by the FCA. For a PRC-based issuer, this can lead to a more protracted due diligence process, particularly around the verification of PRC regulatory approvals and the authenticity of revenue contracts.

Liquidity and Index Eligibility

The fundamental constraint on London as a listing venue is secondary market liquidity. The average daily trading volume on the LSE’s main market for non-UK issuers was GBP 12.3 million in 2024, compared to HKD 1.2 billion on the HKEX Main Board for the same cohort (LSEG data, HKEX Monthly Market Statistics, December 2024). For a company that requires a liquid market for future secondary offerings or as a currency for acquisitions, London’s thin trading depth is a significant liability. The FTSE UK Index Series inclusion criteria require a minimum free float of 25% and a median daily trading volume of at least 0.05% of the company’s issued share capital over the preceding 12 months (FTSE Russell Ground Rules, Version 14.2, January 2025). An issuer listing with a 10% free float under the new ELR will not qualify for FTSE index inclusion, which in turn reduces institutional investor demand.

The Comparative Matrix: Regulatory, Structural, and Tax Considerations

To synthesise the jurisdictional differences, a structured comparison across four dimensions—regulatory burden, listing timeline, cost structure, and post-listing flexibility—is necessary.

Regulatory Burden and Ongoing Compliance

The HKEX imposes the most prescriptive ongoing compliance requirements of the three venues. A Main Board issuer must publish annual reports within four months of the financial year-end (Rule 13.46(1)(a)), interim reports within three months (Rule 13.48(1)(a)), and quarterly financial reports under Rule 13.28. The SFC’s Code of Conduct requires a sponsor to remain engaged for at least two financial years post-listing (SFC Code, paragraph 17.9). In New York, an FPI must file an annual report on Form 20-F within four months of the financial year-end, but is exempt from quarterly reporting on Form 10-Q and from the proxy rules under Section 14 of the Exchange Act. The SEC’s requirement for an FPI to provide a reconciliation to US GAAP under Rule 9-01 of Regulation S-X was eliminated in 2007 for issuers using IFRS as issued by the IASB. In London, an issuer admitted under the new ELR must publish an annual financial report within four months and a half-yearly financial report within three months (DTR 4.1.3R and DTR 4.2.2R). The UK’s Corporate Governance Code applies on a “comply or explain” basis, but the new ELR removed the requirement for a listed company to have a board that is at least 50% independent non-executive directors.

Listing Timeline and Execution Certainty

A traditional IPO on the HKEX takes 6–9 months from the date of A1 filing to the first day of trading, assuming no material regulatory queries. The HKEX’s Listing Committee meets weekly, and the average number of rounds of comments from the Listing Division is three to four. In New York, an FPI filing a Registration Statement on Form F-1 can expect an SEC review period of 8–12 weeks for a first-time filer, with two to three rounds of comments. The total timeline from confidential filing to pricing is typically 5–7 months. London’s timeline is the shortest: the FCA’s UK Listing Authority (UKLA) aims to process a listing application within 20 business days of receipt of a complete application, and the total timeline can be as short as 3–4 months. However, this speed advantage is offset by the lower probability of a successful pricing, particularly for issuers from the Asia-Pacific region that lack a pre-existing institutional investor base in London.

Cost Structure

The all-in cost of a Hong Kong Main Board IPO ranges from HKD 80 million to HKD 150 million for a typical HKD 1–2 billion deal, comprising sponsor fees (HKD 15–25 million), legal fees (HKD 10–20 million), and underwriting commissions (2.5–3.5% of the gross proceeds). In New York, the total cost for a USD 200–500 million IPO is approximately USD 15–25 million, with underwriting commissions typically 5–7% of gross proceeds, significantly higher than Hong Kong. The SEC’s registration fee is 0.00136% of the aggregate offering price (as of 2025). In London, underwriting commissions are lower, typically 2–4% of gross proceeds, but the legal and sponsor advisory costs can be comparable to Hong Kong at GBP 5–10 million for a first-time issuer.

Actionable Takeaways

1. For a PRC-based issuer with a VIE structure and a market capitalisation above HKD 15 billion, Hong Kong under Chapter 18C offers the most predictable regulatory pathway, provided the sponsor can deliver a third-party valuation report that satisfies the HKEX’s December 2024 guidance on expected market capitalisation.
2. An issuer targeting a free float below 25% to preserve founder control should evaluate London under the new ELR, where a 10% free float is permissible, but must accept the trade-off of exclusion from the FTSE UK Index Series and significantly lower secondary market liquidity.
3. A US listing remains the optimal venue for a company requiring deep institutional liquidity and a currency for M&A, but the issuer must budget for SOX 404(b) compliance costs of USD 500,000–1.5 million annually and accept a 5–7% underwriting commission structure.
4. The HKEX’s GEM-to-Main Board transfer path is a viable two-step strategy for issuers with a market capitalisation of HKD 500 million to HKD 2 billion, offering a reduced initial compliance burden and a 28-month average timeline to a full Main Board listing.
5. Any issuer with a material PRC operating footprint must engage PRC legal counsel to confirm that the planned listing structure—whether VIE, direct equity, or H-share—complies with the latest PRC securities regulatory commission (CSRC) filing requirements under the newly effective Administrative Provisions on Overseas Securities Offerings and Listings by Domestic Companies (CSRC Order No. 8, effective 31 March 2023), regardless of the chosen venue.